Managing Director

Beth Ehrgott

Ms. Ehrgott, Head of our Global Life Sciences Practice, brings more than 35 years of both global and national business development and executive search expertise to The Alexander Group. She has conducted searches for top C-Suite executives across research and development, commercial, finance, corporate development, tech ops –  manufacturing, quality, and supply chain, legal, corporate affairs and communications, investor relations, information technology, compliance, human resources, and diversity and inclusion for Fortune 500 companies as well as private equity/venture capital backed emerging growth clients across multiple industries, including pharmaceutical, biotech, generics, consumer packaged goods, medical device, manufacturing, not-for-profit, retail, financial services, and professional services.

Ms. Ehrgott serves on the National Board of Advisors of Life Science Cares. Life Science Cares is a nonprofit organization that leverages the power of the life science industry and provides a platform to solve poverty by uniting the human and financial resources of life science companies and industry leaders.

Prior to joining The Alexander Group, Ms. Ehrgott was Head of Talent Acquisition for Europe & ROW as well as Head of Global Talent Acquisition Projects for Novartis Vaccines & Diagnostics. Ms. Ehrgott was tapped by this newly formed division of Novartis not only for her consultative approach to executive search but also for her proven track record to achieve the “slightly impossible.”

Previously, Ms. Ehrgott was Co-founder & Partner of a national interim staffing firm that recruited executive level human resources professionals for a Fortune 500 client base.

She is a Phi Beta Kappa graduate of Lehigh University and a former classical ballet dancer.

"Search is in my DNA. Nothing gives me more joy than recruiting a purpose-driven leader whose mission is to transform public health and patient outcomes."

Education

  • Lehigh University

    Bachelor of Arts, Psychology/Sociology and Spanish

Industry Experience

Life Sciences
Consumer Packaged Goods
Manufacturing
Not-For-Profit
Retail
Financial Services

What do you think differentiates The Alexander Group from other executive search firms?

Many things but most importantly is our seamless fluidity with our clients and internal team. Most firms have an externally facing team who engage with their clients but often there is a disconnect with their internal team. Our external client partner and team are the same people who execute each phase of the search - from conducting fresh research for every search to full candidate assessment and interviews and all client and candidate communications from search kickoff through completion. We are extremely client and team focused and function as a welcomed extension of our client team as opposed to an external third party.

What’s the highest compliment a client can give you?

Repeat business and unsolicited endorsement by others.

What do you love about your work?

The trusted partnerships we have built for decades and continue to build. Within our global life sciences practice, if we can help make a difference for patients, even indirectly, by providing top executive leaders to our clients who are committed with tremendous passion to develop new treatments for unmet needs across every therapeutic area, then sign me up every day! There is nothing better!

Recent Articles

C-Level Recruitment for Boutique Law Firms: Redefining Leadership Excellence

Managing Director, John Mann, discusses recruiting C-level leaders for boutique law firms.

The Emerging Power of the CIO Role in Law Firms: Shaping The Legal Future

We discuss the evolving role of CIOs in law firms, highlighting their shift from technical experts to strategic leaders.

Empty conference room with modern chairs and a large table, symbolizing the impact of a board member resignation on corporate governance.

Board Member Resignation: How to Navigate Corporate Governance Crisis

The Alexander Group advises on responding to a full board resignation, emphasizing urgency, communication, and understanding voting structures.

How is DEI Changing Amid Backlash? Embracing Quiet Diversity Strategies

The Alexander Group explores the evolution of DEI strategies, highlighting the rise of “Quiet DEI” as firms adapt diversity efforts to socio-political changes.

Our Executive Search for Life Sciences Firm Shares Insights From an Outstanding Visionary In Biotechnology

Beth Ehrgott speaks with multi-hyphenate, Luke Timmerman, for our Five Questions With Outstanding Leaders.

The Alexander Group Completes Healthcare Executive Search for Lykos Therapeutics

Allison Rosenthal has joined Lykos Therapeutics as the company’s first Chief Commercial Officer. Ms. Rosenthal leads Lykos’ trailblazing commercial strategy and operations, initially focusing on the potential launch of MDMA-assisted therapy for their lead program to treat those suffering with PTSD. If approved by the FDA, anticipated in Q3 of 2024, this will be the